Skip to main content
. 2017 Aug 14;7:8066. doi: 10.1038/s41598-017-08559-w

Figure 4.

Figure 4

Liver weight, triglyceride content and gene expression of lipid metabolism markers in the maternal and fetal liver. (A) Weight of dams liver (CD-Veh, n = 8; HF/HS, n = 8; CD-DHT, n = 8; HF/HS-DHT, n = 10). (B) Circulating Triglycerides (TG) in serum and (C) TG content in dams liver, (CD-Veh, n = 8; HF/HS-Veh, n = 8; CD-DHT, n = 8; HF/HS-DHT, n = 9). (D) TG content in fetal liver (CD-Veh, n = 7; HF/HS, n = 8; CD-DHT, n = 8; HF/HS-DHT, n = 9). (E) Correlation analyses between TG content in fetal liver and maternal weight gain before pregnancy, (F) Correlation analyses between TG content in fetal liver and percentage of maternal weight gain during pregnancy, (G) Correlation analyses between TG content in maternal liver and percentage of maternal weight gain before pregnancy, (H) Correlation analyses between TG content in maternal liver and percentage of maternal weight gain during pregnancy, (I) Transcription factors, lipogenic enzymes, cholesterol and fat storage mediators in Maternal liver and (J) fetal liver (CD, n = 8; HF/HS, n = 8; CD-DHT, n = 7–8; HF/HS-DHT, n = 10). Values are means ± SEM. a = Main effect of diet, b = main effect of injection, 1 = Interaction between diet and injection.